Diclofenac
Cambia, Diclofenac, LOFENA, Xiclo, ZIPSOR
Nonsteroidal Anti-inflammatory Drug
NADAC/unit
$0.0693
No Shortage
Tier 1: 217.6%
PA Req: 83.6%
41 Manufacturers
64 ANDAs
Diclofenac reduces pain, inflammation, and fever by inhibiting prostaglandin synthesis.
vs. brand Cambia: Generic saves up to 99% per unit
Market Intelligence
2026-02-11 Class II Recall: SUN PHARMACEUTICAL INDUSTRIES INC
2026-01-28 Class III Recall: Cipla USA, Inc.
2023-08-02 Class II Recall: ALEMBIC PHARMACEUTICALS, INC.
Generic Manufacturers
ACTAVIS ELIZABETH LLCACTAVIS MID ATLANTIC LLCALEMBIC PHARMACEUTICALS LTDALKEM LABORATORIES LTDALTAIRE PHARMACEUTICALS INCAMICI PHARMA INCAMNEAL PHARMACEUTICALSAMNEAL PHARMACEUTICALS LLCANNORA PHARMA PRIVATE LTDAPOTEX INCASSERTIO SPECIALTY PHARMACEUTICALS LLCAUROBINDO PHARMA LTDAUROBINDO PHARMA USA INCAUROLIFE PHARMA LLCBAUSCH AND LOMB INCBIONPHARMA INCCARLSBAD TECHNOLOGY INCDEXCEL LTDENCUBE ETHICALS PRIVATE LTDEPIC PHARMA LLCGLENMARK PHARMACEUTICALS LTDINGENUS PHARMACEUTICALS LLCLUPIN LTDLUPIN PHARMACEUTICALS INCNOVEL LABORATORIES INCONESOURCE SPECIALTY PTE LTDPADAGIS ISRAEL PHARMACEUTICALS LTDPH HEALTH LTDRISING PHARMA HOLDINGS INCRK PHARMA INCRUBICON RESEARCH LTDSANDOZ INCSENORES PHARMACEUTICALS INCSUN PHARMA CANADA INCTARO PHARMACEUTICAL INDUSTRIES LTDTEVA PHARMACEUTICALS USA INCTORRENT PHARMACEUTICALS LTDUMEDICA LABORATORIES PRIVATE LTDUNIQUE PHARMACEUTICAL LABORATORIES A DIV OF JB CHEMICALS AND PHARMACEUTICALS LTDVALEANT PHARMACEUTICALS NORTH AMERICAWATSON LABORATORIES INCZYDUS LIFESCIENCES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.